Clinical Trials on Mucositis in Switzerland

Total 13 results

University Hospital, Basel, Switzerland

Completed

Feasibility and Patient Reported Tolerance of Cryotherapy With the Cooral ® Mouth Cooling Device [MCD) in Patients Undergoing Radiation Therapy (CooRay)

Oral Mucositis

Switzerland
University Hospital, Geneva

Completed

Effect of Topical Morphine (Mouthwash) on Oral Pain Due to Chemo- and/or Radiotherapy Induced Mucositis

Cancer | Mucositis

Switzerland
University of Zurich

Completed

Validation of Rehab Assessments in Myositis Patients

Myositis

Switzerland
University of Zurich

Unknown

Rituximab-induced Pulmonary Function Changes

Rheumatoid Arthritis | Inflammatory Myositis

Switzerland
Galera Therapeutics, Inc.

Completed

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Head and Neck Cancer | Oral Mucositis

Spain, Switzerland, Belgium, Poland, Germany, Czechia
Onxeo

Completed

Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis

Oral Mucositis

Spain, United States, France, Germany, Hungary, Switzerland
University Hospital Inselspital, Berne

Completed

Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies (LUNCH1)

Colitis | AML | Mucositis

Switzerland
University of Zurich

Completed

Feasibility of a Blended Therapy Approach (bletheRD)

Feasibility | Exercise | Telemedicine | Myositis | Haemophilia

Switzerland
Novartis Pharmaceuticals

Completed

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients (RESILIENT)

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Neovacs

Withdrawn

Study of IFN-K in Dermatomyositis

Dermatomyositis

Italy, France, Switzerland, Germany
CSL Behring

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) (RECLAIIM)

Dermatomyositis

United States, Argentina, Belgium, France, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Spain, Switzerland, Ukraine
argenx

Recruiting

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. (ALKIVIA)

Myositis | Dermatomyositis | Polymyositis | Antisynthetase Syndrome | Immune-Mediated Necrotizing Myopathy | Active Idiopathic Inflammatory Myopathy

United States, Germany, Spain, Korea, Republic of, Austria, Turkey, Lithuania, Australia, Thailand, Serbia, Poland, Italy, France, Netherlands, Argentina, United Kingdom, Georgia, Belgium, Bulgaria, Canada, Cyprus, Denmark, Greece, Hu... and more

Clinical Trials on Mucositis in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations